Thomas Flohr

Clinical significance of minimal residual disease quantification in adult patients with standard-risk acute lymphoblastic leukemia

Monika Brüggemann, Thorsten Raff, Thomas Flohr et al. · Blood · 2005 · 537 citations

Medicine, Hematology, Oncology +16

A Viral ER-Resident Glycoprotein Inactivates the MHC-Encoded Peptide Transporter

Hartmut Hengel, Jens‐Oliver Koopmann, Thomas Flohr et al. · Immunity · 1997 · 316 citations · Full text

Life Sciences, Immunology, Molecular Biology +14

Activating NOTCH1 mutations predict favorable early treatment response and long-term outcome in childhood precursor T-cell lymphoblastic leukemia

Stephen Breit, Martin Stanulla, Thomas Flohr et al. · Blood · 2006 · 294 citations · Full text

Medicine, Genetics, Oncology +15

A Mouse Cytomegalovirus Glycoprotein Retains MHC Class I Complexes in the ERGIC/cis-Golgi Compartments

H. Ziegler, R Thäle, Pero Lučin et al. · Immunity · 1997 · 264 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +10

Molecular allelokaryotyping of pediatric acute lymphoblastic leukemias by high-resolution single nucleotide polymorphism oligonucleotide genomic microarray

Norihiko Kawamata, Seishi Ogawa, Martin Zimmermann et al. · Blood · 2007 · 199 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17